biospecimen__admin__batch_number	173.73.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	C5653B94-9248-43EC-9958-F638FF70AE4A
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-EP-A2KB-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-EP-A2KB-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-EP-A2KB-01A
biospecimen__bio__biospecimen_barcode_bottom	0113416367
biospecimen__bio__day_of_creation	09
biospecimen__bio__day_of_shipment	31
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	08
biospecimen__bio__month_of_shipment	08
biospecimen__bio__pathology_report_file_name	TCGA-EP-A2KB.DF650AE0-E9E8-48A7-8D39-88A3F7EC2AC7.pdf
biospecimen__bio__plate_column	12
biospecimen__bio__plate_id	A180
biospecimen__bio__plate_row	G
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	2.08
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	13.00
biospecimen__bio__year_of_creation	2011
biospecimen__bio__year_of_shipment	2011
biospecimen__shared__bcr_patient_barcode	TCGA-EP-A2KB
biospecimen__shared__patient_id	A2KB
clinical__ablation__ablation_performed_indicator	NO
clinical__ablation__bcr_ablation_barcode	TCGA-EP-A2KB-A33377
clinical__ablation__bcr_ablation_uuid	950DA764-8CFA-48C1-8ADC-A39018424BE9
clinical__ablation__days_to_embolization_performed	334
clinical__ablation__embolization_performed_indicator	YES
clinical__ablation__embolization_therapy_drug_name	Doxorubicin
clinical__ablation__embolization_type	Chemoembolization
clinical__ablation__embolizing_agent_utilized	Other, specify
clinical__ablation__embolizing_agent_utilized_other	Micron Microspheres
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	47597D04-2B5E-48B4-93F8-359062F4C1B1
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.8
clinical__chol_lihc_shared__albumin_result_specified_value	3.8
clinical__chol_lihc_shared__albumin_result_upper_limit	5.1
clinical__chol_lihc_shared__bilirubin_lower_limit	0.2
clinical__chol_lihc_shared__bilirubin_upper_limit	1.4
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_upper_limit	1.0
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	9
clinical__chol_lihc_shared__fetoprotein_outcome_value	2128
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis C
clinical__chol_lihc_shared__hist_hepato_carcinoma_risk	Cirrhosis, Alcohol abuse
clinical__chol_lihc_shared__platelet_result_lower_limit	140
clinical__chol_lihc_shared__platelet_result_upper_limit	415
clinical__chol_lihc_shared__prothrombin_time_result_value	1.4
clinical__chol_lihc_shared__specimen_collection_method_name	Other (specify)
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	46
clinical__clin_shared__bcr_followup_barcode	TCGA-EP-A2KB-F33135
clinical__clin_shared__bcr_followup_uuid	B6FD7C06-6322-48AC-B5CB-012003D05B3E
clinical__clin_shared__day_of_form_completion	18
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__followup_case_report_form_submission_reason	Scheduled Follow-up Submission
clinical__clin_shared__history_prior_surgery_type_other	Right Hepatectomy (Segment 6)
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	3
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	133
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2012
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2011
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	Yes
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	NO
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	161
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Locoregional Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	MX
clinical__shared_stage__pathologic_n	NX
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	0b233eab-4541-4b62-b9ae-baebf672403e
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-EP-A2KB-01A-11R-A180-07
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	092348f7-f665-4602-b065-8c080435ef26,5f4953e6-3a30-4475-8b75-3d42bb56cdc2,df7610ad-a5e9-4232-9dea-701c2530129a
gdc__analysis__workflow_link	https://github.com/NCI-GDC/htseq-cwl
gdc__analysis__workflow_type	HTSeq - FPKM-UQ,HTSeq - FPKM,HTSeq - Counts
gdc__analysis__workflow_version	v1
gdc__analytes__a260_a280_ratio	1.85
gdc__analytes__analyte_id	88a75621-a20f-4041-95ad-98f1f4f97385
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	18c08546-bed3-4ed9-b223-479afe633c8e
gdc__center__center_id	ee7a85b3-8177-5d60-a10c-51180eb9009c
gdc__center__center_type	CGCC
gdc__center__code	07
gdc__center__name	University of North Carolina
gdc__center__namespace	unc.edu
gdc__center__short_name	UNC
gdc__created_datetime	2016-05-26T21:17:22.234186-05:00,2016-05-26T21:17:22.450568-05:00,2016-05-26T21:17:22.021089-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	Gene Expression Quantification
gdc__demographic__demographic_id	1e163eb2-4bc1-5d78-b48f-9513316d15ab
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1965
gdc__diagnoses__age_at_diagnosis	16835
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-16835.0
gdc__diagnoses__days_to_death	596.0
gdc__diagnoses__days_to_last_follow_up	334.0
gdc__diagnoses__diagnosis_id	a3ab57c4-5062-5e33-88f7-777ea976c5d5
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	RNA-Seq
gdc__exposures__bmi	29.752066115702476
gdc__exposures__exposure_id	f968e697-8627-5360-b010-c0adee729cb1
gdc__exposures__height	165.0
gdc__exposures__weight	81.0
gdc__file_id	56d3d224-edaf-43d9-89da-70684b55a937,4065e99a-7faa-46e9-88a7-68b3ea716985,a2858c35-4877-4159-a740-17e579ac02d3
gdc__file_name	ace34e34-d432-4c19-a50a-a00c9f17afbe.FPKM-UQ.txt.gz,ace34e34-d432-4c19-a50a-a00c9f17afbe.FPKM.txt.gz,ace34e34-d432-4c19-a50a-a00c9f17afbe.htseq.counts.gz
gdc__file_size	487735,486334,247069
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	RNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	a584470eb1241e1b75f63980e8ba7a03,add7af53ad29130b097cc3afb331c2cb,7423edfe67827e4b14e2feca2d6e8a36
gdc__portions__is_ffpe	false
gdc__portions__portion_id	2722288d-c6a2-4f75-8473-c1e47c89d390
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	50
gdc__samples__initial_weight	1210.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	DF650AE0-E9E8-48A7-8D39-88A3F7EC2AC7
gdc__samples__sample_id	e2895132-da4f-4db5-b417-510e99fce776
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	3.0
gdc__slides__percent_tumor_cells	97.0
gdc__slides__percent_tumor_nuclei	98.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	3d146fbf-15f0-4778-a8ee-41e9122d30c1
gdc__submitter_id	ace34e34-d432-4c19-a50a-a00c9f17afbe_uqfpkm,ace34e34-d432-4c19-a50a-a00c9f17afbe_fpkm,ace34e34-d432-4c19-a50a-a00c9f17afbe_count
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	EP
gdc__tissue_source_site__name	Christiana Healthcare
gdc__tissue_source_site__tissue_source_site_id	dbcb7cb8-b22c-5a78-9d41-b93e7eb08f05
gdc__treatments__treatment_id	f6eca0e4-a762-50b1-ae7f-f9ed18f4e09c
gdc__type	gene_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T08:05:02.907+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/0b233eab-4541-4b62-b9ae-baebf672403e-geq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/0b233eab-4541-4b62-b9ae-baebf672403e-geq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	5039564
manually_curated__local_md5	078d41991cce90b98021541412206cd7
manually_curated__opengdc_download_date	2018-10-15T16:26:04.000560+02:00
manually_curated__opengdc_file_md5	bb26bc245e602b7188b1d70924619720
manually_curated__opengdc_file_size	1641946
manually_curated__opengdc_id	0b233eab-4541-4b62-b9ae-baebf672403e-geq
manually_curated__origin_file_size	5039564
manually_curated__origin_last_modified_date	Mon Oct 15 16:36:00 CEST 2018
manually_curated__origin_md5	078d41991cce90b98021541412206cd7
manually_curated__tissue_status	tumoral
num	60483
